InvestorWire NewsRoom

InvestorNewsBreak

InvestorNewsBreaks – Grapefruit USA Inc. (GPFT) Submits NNCP Filing with Health Canada
January 25, 2022

InvestorNewsBreaks – Grapefruit USA Inc. (GPFT) Submits NNCP Filing with Health Canada

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, announced that it has filed Form 8-K with Health Canada; the filing is GPFT’s Notice of New Cannabis Product (“NNCP”) with Health Canada. Once GPFT receives approval of the NNCP from Health Canada, the company will be able to offer its patented Hourglass(TM) Time Release THC+CBD-Infused Topical Delivery Cream under the Canadian Federal Cannabis Act throughout Canada. The act, which became effective in 2018, provides national guidelines for legal access to cannabis as well as the product, distribution and sale of the substance. Canada became the second country in the world to formally legalize the cultivation, possession, acquisition and consumption of cannabis and cannabis-based products; it is the first G7 and G20 nation to federally legalize cannabis. Health Canada is the Canadian federal government licensing authority that oversees the implementation of the act, and all cannabis products must meet its federal regulatory requirements before they can be sold in Canada. “A filing on Form 8-K is only appropriate for truly material events,” said Grapefruit CEO and cofounder Bradley J. Yourist in the press release. “The filing of the NNCP is one of the most material events in Grapefruit’s history, as approval by Health Canada will allow us to commence sales of Hourglass technology-based THC and THC/CBD products in the largest federally legal cannabis market in the world. The world’s best cannabis topical delivery cream will then be available in the world’s largest national legal THC market — a perfect complement to Grapefruit’s California sales of THC/CBD Hourglass products and worldwide sales of Hourglass technology powered non-THC, hemp-based CBD products.”

To view the full message, visit https://ibn.fm/5kuUt

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit https://GrapefruitBlvd.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Recent NewsBreaks

NewsBreaks Categories

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).